Company ViewRay, Inc.

Equities

VRAYQ

US92672L1070

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 01:27:50 2024-04-18 pm EDT 5-day change 1st Jan Change
0.000001 USD -90.00% Intraday chart for ViewRay, Inc. 0.00% 0.00%

Business Summary

ViewRay, Inc. is engaged in designing, manufacturing, and marketing the MRIdian MRI-Guided Radiation Therapy System. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic MR imaging with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. The MRIdian is comprised of three components, namely magnetic resonance imaging (MRI) system, radiation delivery system, and integrated treatment planning and delivery software. MRIdian employs MRI-based technology to provide real-time imaging that targets tumors from the surrounding soft tissue and other critical organs, both before and during radiation treatment delivery. MRIdian offers MR-guided imaging that provides tissue visualization compared to cone-beam computed tomography (CBCT), to enable contouring and reduced margins. The Company has installed approximately 56 MRIdian systems at hospitals, which are used to treat a variety of solid tumors.

Number of employees: 295

Sales per Business

USD in Million2021Weight2022Weight Delta
Magnetic Resonance Imaging
77.6 %
52 74.0 % 79 77.6 % +52.95%
Service
21.9 %
18 25.4 % 22 21.9 % +25.81%
Distribution Rights
0.5 %
0 0.7 % 1 0.5 % +8.00%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
50.7 %
42 60.1 % 52 50.7 % +22.88%
Rest of World
30.6 %
14 20.0 % 31 30.6 % +123.09%
Italy
10.2 %
-- 10 10.2 % -
France
7.3 %
8 11.2 % 7 7.3 % -5.77%
United Kingdom
1.0 %
1 1.7 % 1 1.0 % -11.34%
Taiwan
0.2 %
5 6.9 % 0 0.2 % -95.52%

Managers

Managers TitleAgeSince
Chief Executive Officer 52 18-12-31
Founder 53 03-12-31
Director of Finance/CFO 38 18-12-31
Chief Tech/Sci/R&D Officer - 17-12-31
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 17-06-30
Director/Board Member 56 18-07-23
Public Communications Contact - 21-03-31
Investor Relations Contact - 21-11-30
Public Communications Contact - 11-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 60 21-06-10
Director/Board Member 72 20-04-13
Director/Board Member 53 07-12-31
Chairman 63 18-02-01
Founder 53 03-12-31
Director/Board Member 56 18-07-23
Chief Executive Officer 52 18-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 183,402,038 164,184,158 ( 89.52 %) 0 89.52 %

Shareholders

NameEquities%Valuation
Artisan Partners LP
7.935 %
14,553,186 7.935 % - $
Shanghai Fosun Industrial Investment Co., Ltd.
6.535 %
11,984,842 6.535 % - $
11,201,228 6.107 % - $
Scott Drake
0.8678 %
1,591,615 0.8678 % - $
1,425,141 0.7771 % - $
779,368 0.4250 % - $
605,832 0.3303 % - $
491,000 0.2677 % - $
447,056 0.2438 % - $
Sanket Shah
0.2106 %
386,295 0.2106 % - $

Company contact information

ViewRay, Inc.

2 Thermo Fisher Way

44146, Oakwood Village

+440 703 3210

http://www.viewray.com
address ViewRay, Inc.(VRAYQ)